EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Point Prevalence of Penicillin Allergy Amongst Inpatients at a UK Tertiary Care Hospital

Andre Chan, Cameron Wilson, Huseyin Bilgin, Patryk Majewski, Jonathan Snape, Vikki Connell, Neena Bodasing, Krishna Banavathi, Lavanya Diwakar

Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/jcpt/1746272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 30.05.2026. Verfasst von Andre Chan und 8 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Penicillin allergy (Pen A) is the most commonly reported drug allergy worldwide, with approximately 10% of the population carrying this label. However, over 90% of these labels are inaccurate. A Pen A label is associated with increased morbidity, mortality, antibiotic resistance and healthcare costs. Pen A delabelling has become a clinical and public health priority, with recent focus on tools like PenFAST for risk stratification in nonspecialist settings. The aim of this work is to determine the prevalence of Pen A among adult inpatients at a large UK teaching hospital and to stratify their risk of allergic reactions using the validated PenFAST tool. Materials and methods A cross‐sectional point prevalence survey was conducted over two days in June 2024 across two hospital sites of the University Hospital of North Midlands. All adult inpatients (excluding maternity wards) were screened for Pen A using demographic data and drug charts. Patients with a Pen A label were assessed using PenFAST. Statistical analysis was performed to determine prevalence and identify risk categories.

Results

Among 1136 inpatients, 16.3% ( n = 185, 95% CI: 14.2–18.5) were labelled penicillin allergic. Older patients (> 65 years), women and those admitted to medical wards were more likely to carry the label. Pen A label increased the likelihood of diagnosis with other antibiotic allergies (RR: 3.56, 95% CI: 2.52–5.03). Risk stratification identified 55.6% ( n = 85) of patients as low risk (PenFAST ≤ 2), suggesting they could be safely delabelled by nonspecialists.

Conclusion

Pen A prevalence amongst adult inpatients was higher than expected in this study. A significant proportion of inpatients with Pen A are at low risk of true allergy and can potentially be delabelled by nonspecialists using validated clinical history–based tools.

Zitieren

APA

Chan, A., Wilson, C., Bilgin, H., Majewski, P., Snape, J., Connell, V., Bodasing, N., Banavathi, K., & Diwakar, L. (2026). Point Prevalence of Penicillin Allergy Amongst Inpatients at a UK Tertiary Care Hospital. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/1746272

Vancouver

Chan A, Wilson C, Bilgin H, Majewski P, Snape J, Connell V, et al. Point Prevalence of Penicillin Allergy Amongst Inpatients at a UK Tertiary Care Hospital. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/1746272

BibTeX
@article{Chan2026,
  author = {Chan, Andre and Wilson, Cameron and Bilgin, Huseyin and Majewski, Patryk and Snape, Jonathan and Connell, Vikki and Bodasing, Neena and Banavathi, Krishna and Diwakar, Lavanya},
  title = {Point Prevalence of Penicillin Allergy Amongst Inpatients at a UK Tertiary Care Hospital},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jcpt/1746272}
}
Kostenlos starten →